Lonza targets 32%-34% profit margin through 2028
Oct 17 (Reuters) - Swiss contract drug manufacturer Lonza LONN.S on Tuesday said it was targeting an operating profit margin of 32% to 34% between next year and 2028. (Reporting by Ludwig Burger, Editing by Rachel More) ((ludwig.burger@thomsonreuters.com; +49 30 220133634;))